source
- Late-stage mRNA melanoma vaccine shows promise, slowing disease recurrenceA late-stage trial of an mRNA-based cancer vaccine reported that the treatment halted the return of melanoma in patients, providing the first clear evidence of efficacy for this approach. Merck an…
- Nobel Prize honors optogenetics pioneers; Roche licenses Alector’s Parkinson’s enzyme therapyThe Nobel Committee awarded this year’s Physiology or Medicine prize to three scientists whose work created the field of optogenetics. Their discoveries of a light‑sensing protein in algae and its…